#United States #New Orleans #ClaimsFiler #uniQure N.V. #AMT-130

Investor Alert: Crucial Deadline Approaching for uniQure Shareholders

In a significant development for shareholders of uniQure N.V. (NasdaqGS: QURE), ClaimsFiler, a renowned shareholder information service, has issued an alert reminding investors about a vital deadline. If you have incurred losses exceeding $100,000 due to your investment in uniQure, you have until April 13, 2026, to file lead plaintiff applications in a pending securities class action lawsuit.

Background on the Class Action Lawsuit

The class action concerns claims against uniQure and some of its executives regarding their failure to disclose crucial information during the designated Class Period, which spans from September 24, 2025, to October 31, 2025. These disclosures are alleged to have violated federal securities laws, leaving many investors in the dark about the company's operations and the status of its leading drug candidate, AMT-130.

The lawsuit emerged after uniQure conveyed optimistic perspectives about its expectation for accelerated approval from the U.S. Food and Drug Administration (FDA) for AMT-130. However, revelations on November 3, 2025, changed the outlook drastically. The company asserted that the FDA no longer found the Phase I/II studies of AMT-130 sufficient to support a Biologics License Application (BLA) submission, which was originally anticipated for the first quarter of 2026. This shift in the FDA's position caused the company's stock to plummet dramatically, dropping from $67.69 per share to an alarming $34.29 per share, a decline of more than 49% in a single day.

Implications for Investors

For those who purchased or acquired shares of uniQure during the specific Class Period, this lawsuit represents a pivotal opportunity to potentially recover losses. The lead plaintiff application process allows investors to represent the larger class of affected shareholders, which can lead to settlements that compensate for the financial damage incurred due to misleading information and corporate mismanagement.

Investors are encouraged to take immediate action. In addition to filing the necessary applications, they are advised to seek legal counsel for tailored guidance. Interested parties can visit ClaimsFiler’s dedicated website at claims filer.com for further details and assistance. There, they can register for free and access a wealth of resources related to this case and others like it.

About ClaimsFiler

ClaimsFiler focuses on empowering retail investors by providing tools and information to help them navigate the landscape of securities class action settlements. It allows users to register, receive notifications regarding relevant securities cases, and inquire about free evaluations from experienced attorneys. This initiative is aimed at ensuring that investors don't miss out on opportunities for financial recovery.

Conclusion

With the deadline rapidly approaching, affected shareholders of uniQure need to act swiftly. The fallout from the recent revelations about the company highlights the importance of transparency and accountability in corporate practices. Engaging with ClaimsFiler can help investors safeguard their rights and potentially recoup their losses. Don’t miss out on your opportunity—take action now to protect your investments.